Analysis demonstrates changes in environmental risk and staffing in low secure facilities, suggesting quality assurance improvements through HoNOS Secure monitoring.
Purpose This study aims to evaluate the use of HoNOS Secure across three low secure forensic wards (non-LD and LD) as a measure of clinical progress and service effectiveness, and a validated, interpretable Clinician Reported Outcome Measure to support internal audit, quality assurance and commissioner reporting. Design/methodology/approach Routinely collected RiO data were de-identified and anonymised; HoNOS Secure scores were structured in Excel and analysed in Python. Given ordinal data and a modest sample, domain-wise Friedman tests were used, with Bonferroni-adjusted Wilcoxon post hocs where indicated. Findings The largest improvement was Domain E (need for escort; −0.71), indicating reduced procedural restriction. Domains D (staffing; −0.32) and G (environmental/interpersonal risk; −0.23) also declined. Smaller gains appeared in B (risk to self) and A (risk to others). Domains C (building security) and F (risk from others) rose slightly (+0.14 each), changes likely driven by context rather than deterioration. In the LD subgroup, G declined (−0.50) and B improved modestly, while D increased (+0.50) on limited data. No domain reached statistical significance; Domain E approached significance (p = 0.0797). Research limitations/implications The evaluation is on a small, single-Trust sample (n = 30) and 6 / 12-month windows constrain generalisability and may miss longer trajectories; sole reliance on HoNOS Secure may under-detect relational/functional change, especially in neurodivergent groups. Practical implications The evaluation suggests that monitoring anchored on procedural/dynamic domains and HoNOS Secure should be paired with brief qualitative and neuroaffirming indicators, particularly in LD services. Originality/value This study findings position HoNOS Secure as a shared MDT language that maps onto risk meetings, ward rounds and discharge planning, prompting formulation and evidencing progress.
No takes yet. Share an insight, caveat, or question.
Francois Potgieter (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: